Hematopoietic stem cell expansion and generation: the ways to make a breakthrough

Area of Science:

• Stem cell biology and regenerative medicine.

Background:

• Hematopoietic stem cell transplantation (HSCT) pioneered human stem cell therapy, driving interest in treating incurable diseases.
• HSCT is crucial for hematologic malignancies, non-malignant hematologic disorders, immunodeficiencies, and metabolic diseases, with autologous HSCT used post-chemotherapy.
• Hematopoietic stem cells (HSCs) are increasingly explored for regenerative medicine in neurodegenerative and heart diseases.

Purpose of the Study:

• To review methods for generating and expanding hematopoietic stem cells (HSCs).
• To address the limitations in HSC supply for clinical applications.
• To cover the potential of non-hematological sources for replenishing hematological homeostasis.

Main Methods:

• Review of current literature on HSC generation and expansion techniques.
• Analysis of strategies to overcome donor limitations and cell number constraints.
• Examination of proof-of-concept studies for HSC-based regenerative medicine.

Main Results:

• HSCT success has fueled significant interest in stem cell therapy.
• Current HSC supply often insufficient for patient demand.
• Emerging research focuses on HSC generation and expansion for clinical needs.

Conclusions:

• Generating and expanding HSCs is key to overcoming clinical application limitations.
• HSCs hold potential beyond traditional transplantation, including regenerative medicine.
• Exploring non-hematological origins may provide novel solutions for HSC replenishment.